EP0558659A4 - Tnf inhibitors - Google Patents

Tnf inhibitors

Info

Publication number
EP0558659A4
EP0558659A4 EP19920901819 EP92901819A EP0558659A4 EP 0558659 A4 EP0558659 A4 EP 0558659A4 EP 19920901819 EP19920901819 EP 19920901819 EP 92901819 A EP92901819 A EP 92901819A EP 0558659 A4 EP0558659 A4 EP 0558659A4
Authority
EP
European Patent Office
Prior art keywords
tnf inhibitors
tnf
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920901819
Other versions
EP0558659A1 (en
Inventor
Klaus Max Esser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0558659A1 publication Critical patent/EP0558659A1/en
Publication of EP0558659A4 publication Critical patent/EP0558659A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19920901819 1990-11-21 1991-11-20 Tnf inhibitors Withdrawn EP0558659A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61647990A 1990-11-21 1990-11-21
US616479 2000-07-14

Publications (2)

Publication Number Publication Date
EP0558659A1 EP0558659A1 (en) 1993-09-08
EP0558659A4 true EP0558659A4 (en) 1993-10-20

Family

ID=24469639

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920901819 Withdrawn EP0558659A4 (en) 1990-11-21 1991-11-20 Tnf inhibitors

Country Status (14)

Country Link
EP (1) EP0558659A4 (en)
JP (1) JP3204971B2 (en)
KR (1) KR930702896A (en)
AP (1) AP259A (en)
AU (1) AU656938B2 (en)
CA (1) CA2096623A1 (en)
HU (1) HUT65838A (en)
IE (1) IE914034A1 (en)
IL (1) IL100088A (en)
MX (1) MX9102173A (en)
NZ (1) NZ240644A (en)
TW (1) TW222001B (en)
WO (1) WO1992009203A1 (en)
ZA (1) ZA919178B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
WO1995004525A2 (en) * 1993-08-04 1995-02-16 Andrulis Pharmaceuticals Corporation Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US7608262B2 (en) * 1996-02-16 2009-10-27 The Kennedy Institute Of Rheumatology Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
JP2006508996A (en) * 2002-11-27 2006-03-16 アルタナ　ファルマ　アクチエンゲゼルシャフト PDE4 and PDE3 / 4 inhibitors for use in the treatment of cachexia
PT1781657E (en) * 2004-02-14 2013-05-23 Glaxosmithkline Ip Dev Ltd Medicaments with hm74a receptor activity
SI1912991T1 (en) 2005-08-10 2011-03-31 Glaxosmithkline Llc One Franklin Plaza Xanthine derivatives as selective hm74a agonists
EP3205652B1 (en) 2014-10-09 2022-03-09 Guangdong Raynovent Biotech Co., Ltd. Hydroxyl purine compounds and applications thereof
US10399981B2 (en) 2015-10-29 2019-09-03 Guangdong Raynovent Biotech Co., Ltd. Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseases

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2944568A1 (en) * 1979-11-05 1981-05-14 Institut für industrielle Pharmazie F + E GmbH, 8750 Aschaffenburg Sodium 8-chloro-theophyllinate as immunostimulant - which selectively stimulates formation of IGM antibodies
EP0243192A2 (en) * 1986-04-25 1987-10-28 The Wellcome Foundation Limited Antiviral 8-Phenylxanthines
EP0344586A2 (en) * 1988-05-27 1989-12-06 Taiho Pharmaceutical Co., Ltd. Medicine containing a TNF inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US757328A (en) * 1903-02-07 1904-04-12 Boehringer & Soehne Art of preparing xanthin derivatives.
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CH654008A5 (en) * 1979-05-22 1986-01-31 Nestle Sa PROCESS FOR THE PREPARATION OF 1,3,7-TRIALKYLXANTHINES.
IT1200944B (en) * 1982-08-10 1989-01-27 Malesci Sas XANTHINIC DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR THERAPEUTIC USE
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
IT1197516B (en) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa THEOFILLINMETYLANIC AND THEOFILLINMETYLDITIAN DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5015647A (en) * 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
FI891419A (en) * 1989-03-23 1990-09-24 Tampella Oy Ab ANORDNING I EN GAENGOEPPNINGSANORDNING FOER BORRMASKINERI.
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2944568A1 (en) * 1979-11-05 1981-05-14 Institut für industrielle Pharmazie F + E GmbH, 8750 Aschaffenburg Sodium 8-chloro-theophyllinate as immunostimulant - which selectively stimulates formation of IGM antibodies
EP0243192A2 (en) * 1986-04-25 1987-10-28 The Wellcome Foundation Limited Antiviral 8-Phenylxanthines
EP0344586A2 (en) * 1988-05-27 1989-12-06 Taiho Pharmaceutical Co., Ltd. Medicine containing a TNF inhibitor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALLERGOLOGIA vol. 11, no. 5, 1983, pages 321 - 327 G. GILLISSEN 'THE BILATERAL EFFECT OF THEOPHYLLINE ON IMMUNE RESPONSE MECHANISMS' *
CURRENT OPINION IN THERAPEUTIC PATENTS vol. 2, no. 10, October 1992, pages 1597 - 1599 'NOVEL XANTHINES AS TNF INHIBITORS' *
CYTOKINE vol. 2, no. 3, May 1990, pages 205 - 210 S. BAILLY ET AL. 'DIFFERENTIAL REGULATION OF IL 6, IL 1, IL 1beta AND TNFalpha PRODUCTION IN LPS-STIMULATED HUMAN MONOCYTES: ROLE OF CYCLIC AMP' *
See also references of WO9209203A1 *

Also Published As

Publication number Publication date
AU9115991A (en) 1992-06-25
IL100088A0 (en) 1992-08-18
HU9301509D0 (en) 1993-11-29
TW222001B (en) 1994-04-01
MX9102173A (en) 1992-06-01
JPH06506192A (en) 1994-07-14
JP3204971B2 (en) 2001-09-04
AP9100335A0 (en) 1992-01-31
IE914034A1 (en) 1992-06-03
HUT65838A (en) 1994-07-28
NZ240644A (en) 1994-08-26
AU656938B2 (en) 1995-02-23
CA2096623A1 (en) 1992-05-22
KR930702896A (en) 1993-11-29
WO1992009203A1 (en) 1992-06-11
EP0558659A1 (en) 1993-09-08
IL100088A (en) 1995-07-31
AP259A (en) 1993-06-03
ZA919178B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
SG46381A1 (en) Leukoriene biiosynthese inhibitor
GB9116684D0 (en) Corrosion inhibitors
EP0746367A4 (en) Easy intubator
AU8292091A (en) Tnf inhibitors
ZA922420B (en) Grf-analogs ii
BG95816A (en) New sulphonylcarbamides
ZA925051B (en) Corrosion inhibitors
GB9200551D0 (en) Suspensory
EP0452257A3 (en) Novel platelet-aggregation inhibitors
HU9301509D0 (en) Tnf inhibitors
GB2244944B (en) Vice
ZA931222B (en) TNF inhibitors
GB9122735D0 (en) Methods
IL99953A0 (en) Ester inhibitors
EP0543936A4 (en) Renin inhibitors
GB9122721D0 (en) Methods
GB2259570B (en) Spirit level
ZA916059B (en) Tnf inhibitors
GB9026251D0 (en) Netalloproteinase inhibitors
ZA914716B (en) Ace inhibitors
CA68400S (en) Block
CA69300S (en) Block
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
ZA911921B (en) Scraper
AU115316S (en) Level

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930515

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930827

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970603